Eric M. Genden, M.D., M.H.C.A., F.A.C.S. is the Isidore Friesner Professor and Chairman of Otolaryngology-Head and Neck Surgery and Professor of Neurosurgery, and Immunology at Icahn School of Medicine at Mount Sinai. He is Chairman of Otolaryngology-Head and Neck Surgery, Executive Vice President of Ambulatory Surgery, and Director of the Head and Neck Institute at the Mount Sinai Health System.
After completing his residency training at Washington University and Barnes-Jewish Hospital, Dr. Genden completed his fellowship training in head and neck oncology and microvascular surgery at The Mount Sinai Medical Center. Dr. Genden also achieved a Masters in Healthcare Administration at Harvard University.
Dr. Genden is internationally recognized as a leader in the management of oral cancer and microvascular reconstruction of the head and neck. His clinical expertise also encompasses thyroid and parathyroid surgery. Dr. Genden’s basic science laboratory focuses on transplantation immune biology of the trachea and larynx. Additionally, he is a co-investigator on more than 15 clinical trials. Dr. Genden has published nearly two-hundred manuscripts and chapters, and is the author and editor of five books.
Icahn School of Medicine’s Head and Neck Cancer Research Program
Watch Videos Featuring Dr. Genden:
In the News
U.S. News & World Report: “Too Many Unnecessary Thyroid Biopsies Performed, Experts Say.”
New York Daily News Daily Checkup feature: “How to Safeguard the Health of Your Thyroid.”
MD, Mount Sinai School of Medicine
Barnes Jewish Hospital
Fellowship, Head & Neck Surgery
Mount Sinai Hospital
Broyles- Maloney Award, Honorable Mention
American Broncho-esophagology Association
The Combined Otolaryngology Spring Meeting
Educator of the Year
Mount Sinai School of Medicine
Department of Otolaryngology-Head and Neck Surgery
Best Clinical Innovations Award
The Academy of Osseointegration, 18th Annual Meeting
The use of Osseointegrated Implants in Maxillary Reconstruction
Head and Neck Surgery's Honor Award
American Academy of Otolaryngology
Physician of the Year
The Mount Sinai Medical Center
Resident Research Program Presentation, First Place
New York Academy of Sciences
Excellence in Teaching
Genden EM, Ferlito A, Shaha AR, Talmi YP, Robbins KT, Rhys-Evans PH, Rinaldo A. Complications of neck dissection. Acta Otolaryngol 2003 Sep; 123(7): 795-801.
Genden EM, Ferlito A, Shaha AR, Rinaldo A. Management of cancer of the retromolar trigone. Oral Oncol 2003 Oct; 39(7): 633-7.
Genden EM, Okay D, Stepp MT, Rezzaee RP, Mojica JS, Buchbinder D, Urken ML. Comparison of functional and quality-of-life outcomes in patients with and without palatomaxillary reconstruction: a preliminary report. Arch Otolaryngol Head Neck Surg 2003 July; 129(7): 775-80.
Teng MS, Genden EM, Buchbinder D, Urken ML. Subcutaneous mandibulotomy: a new surgical access for large tumors of the parapharyngeal space. Laryngoscope 2003 Nov; 113(11): 1893-7.
Genden EM, Urken ML. Laryngotracheal Transplantation: Ethical Limitations. Mt Sinai J Med 2003 May; 70(3): 163-5.
Genden EM, Rinaldo A, Suarez C, Wei WI, Bradley PJ, Ferlito A. Complications of free flap transfers for head and neck reconstruction following cancer resection. Oral Oncol 2004 Nov; 40(10): 979-84.
Robbins KT, Ferlito A, Suarez C, Brizel DM, Bradley PJ, Pellitteri PK, Clayman GL, Kowalski LP, Genden EM, Rinaldo A. Is there a role for selective neck dissection after chemoradiation for head and neck cancer? . J Am Coll Surg 2004 Dec; 199(6): 913-6.
Genden EM, Rinaldo A, Shaha AR, Bradley PJ, Rhys-Evans PH, Ferlito A. Pharyngocutaneous fistula following laryngectomy. Acta Otolaryngol 2004 Mar; 124(2): 117-20.
Morris L, Govindaraj S, Genden EM. Primary sphenoid sinus esthesioneuroblastoma. Am J Otolaryngol 2004 Sep-Oct; 25(5): 350-3.
Wallace D, Genden EM, Urken ML. Reconstruction of the hard palate with the radial forearm free flap: Outcomes and Quality of Life. Head Neck 2004 Sep; 26(9): 808-14.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Genden did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.